Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901
Publication
, Conference
Heimall, J; Logan, BR; Cowan, MJ; Notarangelo, LD; Griffith, LM; Puck, J; Parikh, S; O'Reilly, RJ; Pai, S-Y; Hanson, IC; Martinez, C; Kohn, DB ...
Published in: Biology of Blood and Marrow Transplantation
February 2015
Duke Scholars
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2015
Volume
21
Issue
2
Start / End Page
S289 / S291
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Heimall, J., Logan, B. R., Cowan, M. J., Notarangelo, L. D., Griffith, L. M., Puck, J., … Buckley, R. H. (2015). Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901. In Biology of Blood and Marrow Transplantation (Vol. 21, pp. S289–S291). Elsevier BV. https://doi.org/10.1016/j.bbmt.2014.11.459
Heimall, Jennifer, Brent R. Logan, Morton J. Cowan, Luigi D. Notarangelo, Linda M. Griffith, Jennifer Puck, Suhag Parikh, et al. “Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901.” In Biology of Blood and Marrow Transplantation, 21:S289–91. Elsevier BV, 2015. https://doi.org/10.1016/j.bbmt.2014.11.459.
Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck J, et al. Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2015. p. S289–91.
Heimall, Jennifer, et al. “Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901.” Biology of Blood and Marrow Transplantation, vol. 21, no. 2, Elsevier BV, 2015, pp. S289–91. Crossref, doi:10.1016/j.bbmt.2014.11.459.
Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck J, Parikh S, O’Reilly RJ, Pai S-Y, Hanson IC, Martinez C, Pulsipher MA, Kapoor N, Goldman F, Kletzel M, Filipovich L, Cuvellier G, Thakar M, Burroughs L, Knudsen A, Connelly JA, Quigg TC, Smith AR, Sullivan K, Loechelt BJ, Gillio AP, Haddad E, Kohn DB, Fleisher T, Shearer W, Dvorak CC, Buckley RH. Early Hematopoietic Cell Transplant (HCT) Outcomes of Children with Severe Combined Immunodeficiency Disease (SCID): The First Seventy Four Patients of the Primary Immune Deficiency Treatment Consortium (PIDTC) Prospective Study 6901. Biology of Blood and Marrow Transplantation. Elsevier BV; 2015. p. S289–S291.
Published In
Biology of Blood and Marrow Transplantation
DOI
ISSN
1083-8791
Publication Date
February 2015
Volume
21
Issue
2
Start / End Page
S289 / S291
Publisher
Elsevier BV
Related Subject Headings
- Immunology
- 1103 Clinical Sciences